drugset
drugset / Trial / NCT03001817

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

NCT03001817 ↗

Phase 3 Completed 551 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients with fasting high triglyceride levels ≥500 mg/dL and \<2000 mg/dL and normal renal function.

Timeline

Start
2016-11-28
Primary completion
2019-06-24
Completion
2019-06-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule — —
Comparator K-877 Unknown — —

Indications

No indication recorded.